Form 4: SAB Biotherapeutics Executive Reports Stock Transaction
Insider Transaction (Form 4)
Alexandra Kropotova, CHIEF MEDICAL OFFICER of SAB Biotherapeutics, Inc., reported a transaction in 473 shares of common stock on September 17, 2026.
Summary
- Tax/exercise-price withholding: disposed of 473 Common Stock on September 17, 2026; holds 41,853 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Alexandra Kropotova — Officer (CHIEF MEDICAL OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-17 | Tax/exercise-price withholding | Common Stock | 473 | — | — | 41,853 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-17 | Tax/exercise-price withholding (473 shares) |
Keywords
insider transaction, Form 4, SABS, SAB Biotherapeutics, Inc., neutral, Alexandra Kropotova
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.